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ABSTRACT
The cytoskeleton is widely considered essential for neurulation, yet
the mouse spinal neural tube can close despite genetic and non-
genetic disruption of the cytoskeleton. To investigate this apparent
contradiction, we applied cytoskeletal inhibitors to mouse embryos in
culture. Preventing actomyosin cross-linking, F-actin assembly or
myosin II contractile activity did not disrupt spinal closure. In contrast,
inhibitingRho kinase (ROCK, forwhich there are two isoformsROCK1
and ROCK2) or blocking F-actin disassembly prevented closure, with
apical F-actin accumulation and adherens junction disturbance in the
neuroepithelium. Cofilin-1-null embryos yielded a similar phenotype,
supporting the hypothesis that there is a key role for actin turnover.
Co-exposure to Blebbistatin rescued the neurulation defects caused
by RhoA inhibition, whereas an inhibitor of myosin light chain kinase,
ML-7, had no such effect. We conclude that regulation of RhoA, Rho
kinase, LIM kinase and cofilin signalling is necessary for spinal neural
tube closure through precise control of neuroepithelial actin turnover
and actomyosin disassembly. In contrast, actomyosin assembly and
myosin ATPase activity are not limiting for closure.
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INTRODUCTION
Neurulation is the embryonic process by which the neural plate
becomes converted into a closed neural tube, the developmental
precursor of the brain and spinal cord. Bending of the
neuroepithelium creates the neural folds whose elevation and
fusion are required for neural tube formation. The role of the
cytoskeleton has long been studied in neurulation. Actin
microfilaments are located circumferentially in the apices of
neuroepithelial cells (Sadler et al., 1982) together with non-
muscle myosin II, which is recruited to this site (Kinoshita et al.,
2008; Nyholm et al., 2009). Regulated actomyosin contraction is
often viewed as the principal ‘motor’ that induces apical
constriction, thereby causing the neural plate to bend and close.
This is analogous to proposed mechanisms of other epithelial
invagination events (Sawyer et al., 2010).
Apical actomyosin contraction is regulated by proteins, including
RhoA and Shroom3, which localize to the apical actomyosin
complex. They are linked to the function of apical junctional
complexes: the sites of contractile microfilament insertion
(Hildebrand, 2005; Nishimura and Takeichi, 2008). Interestingly,
planar cell polarity (PCP) proteins, including Celsr1, have also been
implicated in the regulation of actomyosin contractility in neural
tube closure (Nishimura et al., 2012), extending the role of PCP that
is known to function in early neural plate shaping (Wallingford and
Harland, 2002; Ybot-Gonzalez et al., 2007b).
Although actomyosin-driven apical constriction is widely
accepted to drive neurulation, several considerations suggest that
this view might be overly simplistic. First, the neural plate of higher
vertebrates bends focally, at the median hinge point and dorsolateral
hinge points (MHP and DLHPs, respectively), rather than
through generalized invagination of the whole neuroepithelium.
Actin does not localize specifically to hinge points, but is present in
the apices of all neuroepithelial cells (Ybot-Gonzalez and Copp,
1999). Although Shroom3 has been reported to localize to bending
regions in the Xenopus neural plate (Haigo et al., 2003), no specific
protein localization has been described for higher vertebrate
hinge points.
A second challenge is that neuroepithelial-bending sites do not
appear to be locations of active apical constriction. For example, the
MHP of chick and mouse embryos is enriched for wedge-shaped
cells (Schoenwolf and Franks, 1984; Smith et al., 1994), but this
results from a localized prolongation of the cell cycle that causes
nuclei to become basally located within the pseudostratifed
neuroepithelium (Smith and Schoenwolf, 1988). The apices of
MHP cells appear to narrow passively as a secondary result of basal
cell expansion.
A third line of evidence comes from experimental disruption
of the cytoskeleton during closure. In the chick, the actin-
microfilament inhibitor cytochalasin D (CytD) blocks only the
later stages of neurulation and considerable neural fold elevation
occurs in its presence (Schoenwolf et al., 1988). In mammals,
although cytochalasins are potent inhibitors of cranial neural tube
closure, both in vivo (Austin et al., 1982; Wiley, 1980) and in
cultured embryos (Morriss-Kay and Tuckett, 1985), spinal
neurulation is resistant to CytD. Following actin microfilament
disassembly in cultured mouse embryos, closure progresses and
the MHP and DLHPs continue to form (Ybot-Gonzalez and
Copp, 1999). Consistent with this, cytochalasins fail to induce spina
bifida when administered in vivo (Austin et al., 1982; Wiley, 1980).
Finally, the findings with cytoskeletal inhibitors are mirrored in
studies of mice with null mutations in cytoskeletal genes. Cranial
NTDs (exencephaly) are seen in mutants lacking a single
cytoskeletal protein [e.g. palladin, vinculin, cofilin 1 (CFL1) and
MARCKS], in double and triple mutants of actin regulatory proteins
(e.g. MENA, VASP and EVL), and in mice lacking protein kinases
with cytoskeletal influence (e.g. ABL1 and ABL2, andMAPK8 and
MAPK9) (Copp and Greene, 2010). In contrast, spinal neurulationReceived 13 October 2014; Accepted 28 May 2015
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occurs normally in such embryos. Only knockouts of the
cytoskeleton-associated proteins Shroom3 and MARCKS-related
protein (Hildebrand and Soriano, 1999; Wu et al., 1996) yield both
exencephaly and spina bifida and, even here, the frequency of
exencephaly exceeds spina bifida. Hence, although the actomyosin
cytoskeleton appears essential for cranial neurulation, its role in
spinal closure is unclear.
Here, we examined in detail the role of the cytoskeleton in mouse
spinal neural tube closure. Inhibitors were used to block specific
cytoskeletal events in cultured embryos whereas closure was also
examined inmice genetically null for the cytoskeletal protein cofilin 1.
We show that actomyosin assembly and ATPase-dependent myosin
contractile function are not limiting in spinal neural tube closure. In
contrast, there is an essential role for F-actin turnover with the
disassembly of actomyosin complexes being a crucial step that,
when inhibited, leads to severe compromise of neurulation.
RESULTS
Inhibition of RhoA signalling disrupts the progression of
spinal neural tube closure
Mouse embryos were explanted between embryonic days (E) 8.5
and 9.5, after neural tube closure had been initiated. Following
culture for 5–6 h in the presence of cytoskeletal inhibitors, the
length of spinal axis occupied by open neural folds (the posterior
neuropore; PNP; Fig. 1A) was taken as a measure of neural tube
closure progression. PNP enlargement indicates neurulation delay
or cessation and predisposition to spina bifida (Copp, 1985).
Dose–response studies were used to select inhibitor
concentration: we generally used the highest concentration at
which general embryonic toxicity was not observed (supplementary
material Table S1). CytD, a drug preventing polymerization of actin
monomers (Flanagan and Lin, 1980), induced exencephaly at high
frequency (not shown) but had no effect on spinal closure (Fig. 1B)
Fig. 1. Inhibition of RhoA signalling disrupts spinal neural tube closure. (A) Mouse embryos cultured for 18 h to the 24 somite stage. Exposure to 5 µM
Y27632 yields an enlarged PNP (between arrowheads), open forebrain (asterisks) and defective heart looping (h) compared with the DMSO control. Inset,
method of PNP length measurement, between the dashed lines. Scale bar: 0.5 mm. (B) Progressive closure of PNP is arrested after the 13 somite stage in
embryos cultured for 5–6 h in Y27632 (**P<0.001 versus DMSO). Embryos exposed to 50 µM Blebbistatin or 0.05 µg/ml CytD close at the same rate as DMSO
controls. (C) PNP closure is significantly delayed after culture in ROCK inhibitor Y27632 or HA-1100, for 18–20 h to the 15–19 or 20–24 somite stage (**P<0.001
versus DMSO). Embryos cultured in Blebbistatin, CytD or LatB resemble DMSO controls. (D) Immunohistochemistry (green, anti-pMLC; nuclei, DAPI) shows
apically localized pMLC (arrowheads) in DMSO- and Blebbistatin-treated embryos with 19 somites. The signal is abolished by 5–6 h culture in Y27632. Grayscale
insets, pMLC staining only. Scale bar: 30 µm. (E) Western blots for pLIMK and LIMK, p-cofilin and cofilin, and pMLC and MLC. The level of the phosphorylated
forms are quantified as a proportion of the total, after normalizing to GAPDH. Culture for 5–6 h in Y27632 significantly reduces the relative amount of pMLC,
pLIMK and p-cofilin compared with DMSO controls, whereas Blebbistatin has no effect (n=3, **P<0.001). (F) G-LISA assay of active GTP-bound RhoA (top)
relative to total RhoA (below), normalized to DMSO (mean±s.d.). Y27632-treated embryos have significantly reduced RhoA activation whereas total RhoA does
not differ between treatments (n=3, *P<0.001). Significance values were calculated with a Student’s t-test, compared with DMSO control.
2469
RESEARCH ARTICLE Journal of Cell Science (2015) 128, 2468-2481 doi:10.1242/jcs.164574
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
consistent with previous findings (Wiley, 1980; Ybot-Gonzalez and
Copp, 1999). Moreover, treatment with Blebbistatin which blocks
myosin II in an actin-detached state and prevents actomyosin cross-
linking (Kovacs et al., 2004), also induced exencephaly but did not
affect spinal closure (Fig. 1B), even when assessed over a fourfold
concentration range (supplementary material Fig. S1A,D). In
marked contrast, treatment with Y27632, a selective inhibitor of
Rho kinase (ROCK, for which there are two isoforms ROCK1 and
ROCK2) (Uehata et al., 1997), delayed spinal closure. After only
5–6 h exposure, Y27632-treated embryos had significantly enlarged
PNPs compared with DMSO controls (Fig. 1A,B; supplementary
material Fig. S1B), consistent with a report of neurulation
disturbance by Y27632 in chick embryos (Wei et al., 2001).
To test whether Blebbistatin might require more prolonged
exposure to be effective, or whether Y27632 had only a temporary
effect,we cultured embryos for 18–20 h, to the 15–19or 20–24 somite
stage. All three inhibitors gave a similar result as in the short-term
exposure: CytD and Blebbistatin did not affect spinal closure whereas
Y27632 produced enlarged PNPs (Fig. 1C; supplementary material
Fig. S1B). Even longer culture, to the 25–36 somite stage when PNP
closure is usually completed, yielded closed PNPs in embryos
exposed to CytD (9/10 closed), Blebbistatin (7/7) andDMSO (12/12),
but persistently open PNPs in Y27632-treated embryos (0/14 closed).
To replicate the effects of CytD and Y27632, we cultured
embryos in additional inhibitors: Latrunculin B (LatB), an inhibitor
of actin polymerization (Spector et al., 1989), had no effect on PNP
closure, like CytD (Fig. 1C; supplementary material Fig. S1B),
whereas hydroxyfasudil (HA-1100), another ROCK inhibitor
(Shimokawa et al., 1999), delayed PNP closure in a manner that
was very similar to Y27632 (Fig. 1C; supplementary material
Fig. S1B). We conclude that ROCK inhibition (either by Y27632 or
HA-1100) blocks the progression of mouse spinal neurulation,
whereas CytD, LatB and Blebbistatin have no effect.
Abnormal actomyosin accumulation in ROCK-inhibitor-
treated embryos
Effectiveness and specificity of inhibitors was assessed by
immunoblotting and immunohistochemistry. Y27632 inhibits
ROCK-dependent phosphorylation of myosin light chain (MLC),
LIM domain kinase (LIMK, for which there are two isoforms LIMK1
and LIMK2) and cofilin (here, we use an antibody that recognises
cofilin 1 and cofilin 2; however, as we study an embryonic region
lacking cofilin 2,we detect only cofilin 1) (Maekawa et al., 1999), and
we detected marked diminution of phosphorylated MLC (pMLC),
phosphorylated LIMK (pLIMK) and phosphorylated cofilin (p-
cofilin) in Y27632-treated embryos, but not in those exposed to
Blebbistatin (Fig. 1D,E). Using a G-LISA assay, we detected a
reduction of RhoA activity in Y27632-treated embryos (Fig. 1F),
consistent with previous findings (Tang et al., 2012).
Phalloidin staining of neuroepithelial sections (Fig. 2A) revealed
an organized actin network in DMSO-treated control embryos, with
intense signal at the apical surface and aligned microfilaments
within the neuroepithelium. Immunohistochemistry for non-muscle
myosin II heavy chain B (MHCB, also known as MYH10; Fig. 2A)
showed more generalized cellular staining, with marked
colocalization of actin and myosin II at the apical neuroepithelial
surface (Fig. 2A, merge). Both actin and myosin II distribution were
severely disrupted in embryos treated with CytD or Blebbistatin:
only a narrow domain of actomyosin remained visible in the most
apical part of the neuroepithelium (Fig. 2A). We quantified actin
and myosin II staining using a confocal-based scanning method to
provide a basal-to-apical profile of staining intensity for each
neuroepithelium (see supplementary material Fig. S1E). This
showed a striking diminution of both actin and myosin II staining
in the Blebbistatin-treated neuroepithelium, particularly in the
apical region, compared with DMSO (Fig. 2B,C). Combined
exposure to Blebbistatin and CytD further diminished actin and
myosin immunostaining (supplementary material Fig. S2C,D), but
these embryos also showed normal PNP closure (supplementary
material Fig. S1D). Hence, the lack of effect of CytD and
Blebbistatin on spinal neural tube closure occurs despite a major
disruption of actomyosin in the closing neuroepithelium.
Y27632 treatment led to a dramatic enhancement of phalloidin and
anti-MHCB staining at the apical surface of the neuroepithelium
(Fig. 2A). Quantification showed an expansion of the average apical
intensity peak of phalloidin towards the basal neuroepithelial surface
(Fig. 2B), which was highly reproducible between embryos
(supplementary material Fig. S2A). Dividing the apical portion
of the neuroepithelium into three bins, at 71–80%, 81–90% and
91–100% of the normalized basal-to-apical distance (Fig. 2D), we
found a significantly greater proportion of total actin in themore basal
bins after Y27632 treatment (Fig. 2D,E). Biochemical fractionation
showed that ∼70% of total actin is filamentous in Y27632-treated
embryos, whereas only 25% is F-actin in DMSO controls (Fig. 2F;
supplementary material Fig. S2B). In contrast, CytD-treated embryos
contained extremely little F-actin, with the great majority being
soluble G-actin (Fig. 2F; supplementary material Fig. S2B). Anti-
MHCB staining intensity was also markedly redistributed to the
apical neuroepithelial surface after Y27632 (Fig. 2A,C).We conclude
that ROCK inhibition causes an abnormal actomyosin accumulation
apically within the neuroepithelium.
Increased F-actin stabilization is sufficient to delay spinal
neural tube closure
To test whether apical actomyosin accumulation, as seen after Y27632
treatment, might be responsible for defective spinal neurulationwe used
Jasplakinolide (Jasp), a drug that blocks actin depolymerization and
increases the F-actin pool (Cramer, 1999). Culture in Jasp for 18–21 h to
the 15–19 and 20–24 somite stages caused significant closure
delay compared with DMSO controls (Fig. 3A; supplementary
material Fig. S2E). More than 70% of actin was filamentous in these
embryos (Fig. 3B) with a threefold reduction in monomeric G-actin
(supplementary material Fig. S2F). Sections showed a massive
accumulation of colocalized F-actin and MHCB at the apical surface
as well as patches more basally within the neuroepithelium (Fig. 3C).
Quantification confirmed themainly apical accumulation of actomyosin
(Fig. 3D–F), whichwas reproducible between embryos (supplementary
material Fig. S2G). We considered the possibility that inhibition of
ROCK might lead to a RhoA-dependent inhibition of embryonic cell
proliferation or increase in cell death. However, measurement of the
percentage of neuroepithelial cells positive for phosphorylated histone
H3 staining and activated caspase 3 showed that neither cell proliferation
nor programmed cell death was altered in Y27632- or Jasp-treated
embryos (supplementarymaterial Fig.S2H,I).We conclude, therefore,
that F-actin stabilization by Jasp is sufficient to cause apical
actomyosin accumulation and to inhibit spinal neural tube closure.
RhoA signalling requirement for neurulation is independent
of myosin II contractility
Downstream of RhoA, ROCK regulates phosphorylation of LIMK
and MLC (Fig. 4A), with pMLC being a key regulatory component
of myosin II ATPase activity in cellular constriction (Matsumura,
2005). To investigate this pathway, we used ML-7, a specific
inhibitor of MLC kinase (Saitoh et al., 1987). Apical pMLC
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immunostaining was abolished by culture for 5–6 h in 50 µMML-7
(Fig. 4B) and only the levels of pMLCwere reduced in immunoblots
of ML-7-treated embryo extracts, whereas the amounts of
pLIMK and p-cofilin were unaffected (Fig. 4C). Despite these
effects, ML-7 treatment was compatible with early spinal neural
tube closure in embryos over a fivefold concentration range
(Fig. 4D; supplementary material Fig. S3A,B). Embryos treated
with ML-7 had a reduced overall intensity of F-actin and MHCB
immunostaining, whereas the apico-basal distribution was very
similar to that in DMSO controls (Fig. 4E–H). Embryos co-treated
with ML-7 and Blebbistatin closed their PNPs normally
(supplementary material Fig. S1D), despite a dramatic reduction
in phalloidin and MHCB staining (supplementary material
Fig. S2C,D). Hence, the requirement for RhoA signalling in
Fig. 2. ROCK inhibition leads to actomyosin
accumulation in apical neuroepithelium.
(A) Immunohistochemistry for F-actin (phalloidin, red) and
myosin II (anti-MHCB, green). Culture for 5–6 h in CytD
or Blebbistatin strongly reduces apical (arrowheads) and
non-apical (single asterisks) staining. In contrast,
actomyosin appears abnormally extensive after Y27632
treatment (multiple asterisks). Note the presence of the
MHP (white dot) and DLHPs (red arrowheads) in both
Y27632-treated and DMSO control embryos. Right,
enlargement of the boxed areas. The yellow box in top left
image shows the typical area of neuroepithelium in which
basal-to-apical staining intensity was measured. Embryos
shown have 17–19 somites. Scale bars: 30 µm.
(B,C) Intensity profile scans of phalloidin (B) and anti-
MHCB (C) staining along the neuroepithelial basal-to-apical
axis. Basal surface, 0; apical surface, 100 (a.u., arbitrary
units). F-actin is enhanced apico-basally and MHCB is
redistributed to the apical surface in Y27632-treated
embryos compared with DMSO controls. Blebbistatin
reduces both F-actin and MHCB. (D,E) With maximum
intensity normalized to 100%, the apical domain of
phalloidin staining extends farther basally in Y27632-
treated embryos than in DMSO controls (arrows in D).
Quantification in the three apical neuroepithelial bins
(71–80%, 81–90%, 91–100%) shows that phalloidin
extends significantly more basally in Y27632-treated
embryos compared with DMSO (**P<0.001 in E).
(F) Biochemical fractionation of F- and G-actin. Stable
F-actin represents 70%of actin in Y27632-treated embryos,
only 25% in DMSO controls and less than 3% after CytD
treatment (**P<0.001). Significance values were calculated
with a Student’s t-test, compared with DMSO control.
2471
RESEARCH ARTICLE Journal of Cell Science (2015) 128, 2468-2481 doi:10.1242/jcs.164574
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
spinal neurulation is unlikely to be mediated through contractility
that is dependent on myosin II ATPase.
Preventing actomyosin accumulation by Blebbistatin
rescues Y27632-induced defects
We asked whether preventing the abnormal accumulation of
actomyosin in Y27632-treated embryos might ameliorate their
spinal neurulation defects. Simultaneous exposure to Y27632
and Blebbistatin, or 5–6 h in Y27632 followed by 13–15 h in
Blebbistatin, produced embryos with PNP lengths that were very
similar to that in DMSO-treated controls (Fig. 5A,B; supplementary
material Fig. S3C–E). Moreover, co-treatment with Y27632 plus
Blebbistatin yielded a largely normal actomyosin distribution
(Fig. 5C), which was confirmed by quantification (Fig. 5D–F).
Fig. 3. Stabilization of F-actin delays spinal neural
tube closure. (A) PNP length is significantly increased
at the 15–19 and 20–24 somite stage after 18–20 h
culture in 10 nM jasplakinolide (Jasp), compared with
DMSO controls (*P<0.05). (B) Biochemical
fractionation shows proportionately increased
F-actin and reduced G-actin in Jasp-treated embryos
relative to DMSO controls (**P<0.001).
(C) Immunohistochemistry (phalloidin, red; anti-
MHCB, green) reveals actomyosin accumulation at the
apical neuroepithelial surface (asterisks) and on some
lateral cell surfaces (arrowheads) after Jasp treatment
(embryos have 20–21 somites). Right, enlargement of
the boxed areas. Scale bars: 30 µm. (D–F) Intensity
profile scans along the neuroepithelial basal-to-apical
axis. Jasp-treated embryos show an extension of
phalloidin staining (intensity normalized to 100%)
towards the basal surface (arrows in D), which is
confirmed by quantification in the most apical 30%
of the neuroepithelium (E; **P<0.001). MHCB staining
intensity (non-normalized) is greater apically in
Jasp-treated embryos than in DMSO controls (F).
Significance values were calculated with a Student’s
t-test, compared with DMSO control.
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The Jasp inhibitory effect on PNP closure also appeared to be
abrogated by co-exposure to Blebbistatin (supplementary material
Fig. S3J,K). In contrast, embryos co-treated with Y27632 plus
ML-7 showed delayed PNP closure like those exposed to Y27632
alone (Fig. 5B; supplementary material Fig. S3C) with abnormal
actomyosin accumulation (Fig. 5C–F). These results argue that
faulty neural tube closure in Y27632-exposed embryos resulted
from abnormal actomyosin accumulation, and not elevated
contractile myosin activity.
We explored in more detail the mechanism by which Blebbistatin
can rescue embryos from the effects of ROCK inhibition. Short-
term culture (5–6 h) in Y27632 followed by culture without
inhibitor (‘washout’) yielded normal PNP lengths (supplementary
material Fig. S3F,H), suggesting that the apparent rescue by
Fig. 4. Spinal neurulation proceeds despite inhibition of myosin II contractility. (A) Downstream effectors of ROCK and inhibitory action of Y27632 and
ML-7. (B) Immunohistochemistry shows absence of pMLC (green; nuclei, DAPI) from apical neuroepithelium of ML-7-treated embryos, compared with DMSO
controls (embryos have 18–19 somites). Grayscale insets, pMLC staining only. Scale bar: 30 µm. (C) Western blots for pLIMK and LIMK, p-cofilin and cofilin,
and pMLC and MLC. Embryos cultured for 5–6 h in ML-7 have significantly reduced the amount of pMLC compared with that in DMSO controls, whereas pLIMK
and p-cofilin are unaffected (n=3, **P<0.001). (D) Culture for 5–6 h in 50 µMML-7 does not significantly affect closure compared with DMSO at the 15–19 somite
stage (n.s.,P>0.05). (E) Immunohistochemistry (phalloidin, red; anti-MHCB, green) of ML-7-treated embryos shows apical actomyosin closely resembling DMSO
controls (arrowheads; see insets on right), whereas actomyosin is reducedmore basally (asterisks). Embryos have 18 somites. Scale bars: 30 µm. (F–H) Intensity
profile scans show unchanged apical phalloidin staining after ML-7 treatment (F), as confirmed by quantification (G; n.s, P>0.05 versus DMSO). The more-basal
phalloidin (F) and MHCB (H; non-normalized) staining is reduced by ML-7. Significance values were calculated with a Student’s t-test, compared with DMSO
control.
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Blebbistatin might be due simply to Y27632 removal. However,
long-term culture (13–15 h) in Y27632 had a persistent adverse
effect on PNP closure, even when the inhibitor was removed,
whereas culture in Blebbistatin following long-term exposure to
Y27632 yielded a normal PNP length (supplementary material
Fig. S3F,H). Moreover, both short-term culture and long-term
culture in Y27632 followed by continued culture in Y27632 plus
Blebbistatin rescued PNP closure at different somite stages
(supplementary material Fig. S3G,H). Embryos from this latter
experiment had a normal F-actin:G-actin ratio (supplementary
material Fig. S3I). Hence, Blebbistatin can rescue PNP closure both
in the absence and presence of Y27632, arguing that it might
prevent ROCK-inhibitor-dependent actomyosin accumulation and
might favour actomyosin disassembly after it has accumulated.
Fig. 5. Prevention of Y27632-related closure
defects by Blebbistatin but not ML-7. (A,B) The
delayed PNP closure seen after culture in 5 µM
Y27632 (B) is rescued by co-exposure to 50 µM
Blebbistatin (A,B; **P<0.001) but not by ML-7 (B; n.s.
P>0.05). Cultures were for 5–6 h (A) or 15–18 h (B),
ending at the somite stages indicated.
(C) Immunohistochemistry (phalloidin, red; anti-
MHCB, green) reveals a normal actomyosin
distribution in embryos co-exposed to Y27632
+Blebbistatin (upper panels; compare with DMSO in
Fig. 2A and Fig. 3C). In contrast, embryos co-exposed
to Y27632+ML-7 (lower panels) show actomyosin
accumulation apically (asterisks), as in those treated
with Y27632 alone (see Fig. 2A). Embryos have 21
somites. (D–F) Intensity profile scans confirm the
expanded apical phalloidin staining in embryos
treated with Y27632 alone, and Y27632+ML-7,
whereas those exposed to Y27632+Blebbistatin
resemble DMSO controls (D). This is confirmed by
quantification (E; **P<0.001; *P<0.05; n.s., P>0.05
compared with DMSO). The MHCB staining profile is
very similar in Y27632+Blebbistatin and DMSO
controls, but markedly abnormal in those treated with
Y27632 alone and Y27632+ML-7 (F). Significance
values were calculated with a Student’s t-test,
compared with DMSO control or indicated sample.
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A key role for cofilin in regulating actomyosin accumulation
and spinal neurulation
Cofilin-mediated actin severing activity (Bamburg, 1999) is
regulated by RhoA and ROCK, through LIMK-mediated
phosphorylation of cofilin (Fig. 4A). We asked whether cofilin 1
(Cfl1)-knockout embryos display reduced neuroepithelial F-actin
turnover, similar to Y27632- and Jasp-treated embryos. Cfl1−/−
embryos have cranial neurulation defects (Gurniak et al., 2005), as
confirmed here (Fig. 6A). During spinal neurulation, PNP length
did not differ between Cfl1−/− and wild-type at 15–19 somites
whereas, by 20–24 somites, Cfl1−/− embryos had significantly
longer PNPs than wild-type or heterozygotes (Fig. 6A,B;
supplementary material Fig. S4A).
Cfl1−/− mutants with 20–24 somites exhibited abnormal actin
accumulation and a marked increase inMHCB immunostaining at the
apical neuroepithelium (Fig. 6C). Importantly, actomyosin
accumulation was already present at the 15–19 somite stage
(supplementary material Fig. S4B), before a difference in PNP
length became evident. Quantification of actin staining showed a basal
expansion of the apical neuroepithelial intensity peak, at both 15–19
and 20–24 somites (Fig. 6D,E). Myosin II staining intensity was
moderately increased in the apical neuroepithelium at 15–19 somites,
and massively increased at 20–24 somites (Fig. 6F). Hence, Cfl1
mutants accumulate actomyosin at the neuroepithelial surface, similar
to Y27632- and Jasp-treated embryos, before the onset of defective
neural tube closure. Moreover, treatment of cultured Cfl1−/− embryos
with Blebbistatin was able to partially restore normal actomyosin
distribution (supplementary material Fig. S4G) and to markedly
reduce PNP length (mean=0.43 mm; n=2) compared with untreated
mutants (mean=0.66 mm; n=5). This confirms the importance of
regulating actomyosin accumulation for spinal neurulation.
Mean PNP length did not differ between Cfl1 heterozygotes and
wild-type at 20–24 somites (Fig. 6B; supplementary material
Fig. S4A). However, four out of ten heterozygotes had PNP
lengths in excess of 0.5 mm, overlapping with Cfl1−/− mutants
(Fig. 6B). Strikingly, actomyosinwasmore intense and expanded at the
apical neuroepithelium in heterozygotes with large PNPs, whereas
actomyosin staining was similar to wild-type when the PNP was small
(Fig. 6G,H; supplementary material Fig. S4C,D). In fact, actomyosin
staining intensity in the sub-apical region of neuroepithelium was
strongly correlated with PNP length (Fig. 6I). Hence, Cfl1
haploinsufficiency causes apical actomyosin accumulation and
defective spinal neurulation in a proportion of embryos.
Actin accumulation affects adherens junctions in a RhoA-
dependent manner
Actomyosin disassembly defects could affect neural tube closure
through disturbance of the stereotypical pattern of neural plate
bending, in which the MHP and paired DLHPs are necessary for
spinal closure (Greene et al., 1998; Shum and Copp, 1996; Ybot-
Gonzalez et al., 2002). Inhibitor-treated and Cfl1 mutant embryos
with delayed PNP closure delay had relatively normal DHLPs
(Fig. 2A, Fig. 3C, Fig. 4B and Fig. 5C; supplementary material
Tables S2, S3). In contrast, we noted a reproducible lack of MHP
bending in Cfl1−/− embryos and in those treated with Y27632 or
Jasp, specifically at the 20–24 somite stage but not at the 15–19
somite stage (supplementary material Tables S2, S3). Hence, a lack
of focal midline neuroepithelial bending could mediate the effects
of actomyosin accumulation at later stages of spinal neurulation.
Another possibility is that abnormal actomyosin accumulation
might affect the structure and/or function of apical junctional
complexes, which are implicated in neuroepithelial morphogenesis
(Nishimura and Takeichi, 2009). Indeed, cofilin plays a defined role
in junctional complex remodelling (Chu et al., 2012). In wild-type
embryos, β-catenin specifically localized to the lateral membranes
of neuroepithelial cells with apical enrichment at adherens
junctions, where it colocalized with phalloidin (Fig. 7A, WT). In
contrast, Cfl1−/− embryos, and heterozygotes with large PNPs,
exhibited a markedly disorganized β-catenin staining, both apically
and deeper within the epithelium, which colocalized with ectopic
F-actin (Fig. 7A; supplementary material Fig. S4D). Exposure
of Cfl1−/− embryos to Blebbistatin in culture largely normalized
β-catenin immunostaining (supplementary material Fig. S4G).
ZO1 localizes to tight junctions and showed precise
immunolocalization on the apical surface of wild-type
neuroepithelium (supplementary material Fig. S4E). In contrast,
ZO-1 (also known as TJP1) immunostaining was more intense
apically in Cfl1−/− embryos, with ectopic neuroepithelial patches
that colocalized with phalloidin staining (supplementary material
Fig. S4E). This ZO-1 staining defect was not normalized in Cfl1−/−
embryos treated in culture with Blebbistatin (supplementary
material Fig. S4H).
Immunostaining for β-catenin in Jasp- and Y27632-treated
embryos revealed abnormally intense apical signal that was
organized into clusters colocalizing with F-actin (Fig. 7A). In
contrast, ML-7 or Blebbistatin exposure did not alter β-catenin
immunolocalization apically, although staining was reduced on
lateral membranes. Embryos cultured in Y27632 plus Blebbistatin
exhibited a β-catenin distribution resembling that in DMSO controls
(Fig. 7A). ZO-1 immunostainingwas confined to the apical surface of
the neuroepithelium in all cultured embryos, with no discernible
abnormalities in inhibitor-treated embryos (supplementary material
Fig. S4F). Hence, adherens junctions are dramatically disrupted in
Cfl1−/− embryos and, less severely, when ROCK signalling and
F-actin disassembly are inhibited. Tight junctions are defective in
Cfl1mutants but not after inhibitor treatment. This suggests that actin
turnover is essential in enabling adherens junctions remodelling as the
spinal neuroepithelium undergoes morphogenesis.
DISCUSSION
We have examined the cytoskeletal requirements for mouse
spinal neural tube closure, using inhibitor-treated and Cfl1 mutant
embryos. The RhoA, ROCK, LIMK and cofilin signalling pathway
regulates F-actin turnover in the mouse neuroepithelium and was
shown to be essential for closure. Surprisingly, prevention of
actomyosin cross-linking (by treatment with Blebbistatin) or F-actin
assembly (by treatment with CytD or LatB) did not halt mouse
spinal neurulation. In contrast, inhibiting Rho kinase (by Y27632 or
HA-1100) or blocking F-actin disassembly (by Jasp and in Cfl1
mutants) arrested closure. Actomyosin accumulation at the apical
neuroepithelial surface correlated strongly with closure defects.
Importantly, when the accumulated actomyosin was disassembled
by Blebbistatin, neurulation disorders were rescued, wholly or
partially, in Y27632- and Jasp-treated embryos and in Cfl1mutants.
In contrast, ML-7, which inhibits myosin II contractile activity, was
unable to rescue the closure defects. These findings suggest that
apical actomyosin accumulation is causally related to failure of
neural tube closure.
Requirement for precise regulation of RhoA, ROCK, LIMKand
cofilin signalling
Apical actomyosin accumulation and closure failure resulted from
either ROCK inhibition or Cfl1 mutation. However, inhibition of
ROCK, by diminishing the sequential phosphorylation of LIMK
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Fig. 6. Requirement for RhoA signalling is through the LIMK and cofilin pathway. (A) E9.5 embryos fromCfl1+/−×Cfl1+/−mating. Homozygotes (top right) are
smaller than wild-type (WT), and exhibit exencephaly (arrow) and enlarged PNP (arrowheads). Heterozygotes (lower panels) appear normal, except some have
an enlarged PNP. Scale bar: 0.5 mm. (B) PNP length is significantly increased at 20–24 somites, but not at 15–19 somites, in Cfl1−/−mutants compared with WT
and heterozygotes (**P<0.001). (C) Immunohistochemistry (phalloidin, red; anti-MHCB, green) shows apical actomyosin accumulation in Cfl1−/− mutants
(asterisks) but not in WT, at 21–22 somites. Right: enlargement of the boxed regions. Scale bar: 30 µm. (D–F) Intensity profile scans show that phalloidin staining
extends more basally in Cfl1−/− embryos than in WT (arrows in D; intensity normalized to 100%), which is confirmed by quantification (E; **P<0.001). MHCB is
redistributed to the apical surface inCfl1−/− embryos at both 15–19 and 20–24 somites (F; not normalized). (G,H) Phalloidin staining extendsmore basally (G) and
MHCB staining is more intense apically (H) in Cfl1 heterozygous embryos with enlarged PNPs, whereas those with small PNPs resemble WT. (I) Phalloidin
staining intensity in the 71–80% basal-to-apical bin of neuroepithelium (see D) correlates with PNP length in individual Cfl1+/− (green and blue symbols) and WT
embryos. Significance values were calculated with a Student’s t-test, compared with WT control.
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and cofilin (Bamburg, 1999), produces abundant active cofilin
whereas Cfl1 mutants lack cofilin activity. These findings suggest a
model (Fig. 7B) in which actin turnover in the neuroepithelium, and
spinal neural tube closure, depend on finely tuned signalling
through the RhoA, ROCK, LIMK and cofilin pathway. Cofilins
sever actin filaments at low-cofilin-binding density whereas, at high
Fig. 7. See next page for legend.
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concentration, cofilin can nucleate actin assembly through
monomer binding (Andrianantoandro and Pollard, 2006; Ghosh
et al., 2004). Cofilin depletion leads to actomyosin accumulation
through a mechanism in which cofilin competitively inhibits
myosin II binding to F-actin (Wiggan et al., 2012). Hence,
increased active cofilin in Y27632-treated embryos and its
absence in Cfl1 mutants can both generate stable F-actin in the
neuroepithelium. We conclude that mouse spinal neurulation
requires precisely regulated ROCK signalling to maintain a
balance between cofilin-mediated actin severing and nucleation,
ensuring actin turnover and actomyosin disassembly at the apical
neuroepithelium.
Mechanisms of faulty neurulation in embryos with apical
actomyosin accumulation
The process of elevation and dorsal apposition of the spinal neural
folds in mice involves the formation of focal bending sites, at the
midline and dorsolaterally (Greene et al., 1998; Ybot-Gonzalez
et al., 2002, 2007a). Between the sites of bending, the elevating
neural folds appear strikingly straight (Shum and Copp, 1996),
suggesting that the generation and maintenance of overall
neuroepithelial tension is also important for normal neural fold
morphology. The majority of embryos with faulty closure exhibited
apparently normal DLHPs, although MHPs were consistently
absent from embryos with delayed closure at the 20–24 somite
stage. Hence, although faulty midline bending might contribute to
the later stages of closure delay, it seems unlikely that accumulation
of actomyosin initiates closure delay through interference with focal
bending. More likely, disturbance of neuroepithelial tension might
be the primary mechanism by which Y27632- and Jasp-treatment,
and Cfl1 mutation, leads to delay in PNP closure.
Is reduced or enhanced neuroepithelial tension likely to be more
disruptive of neurulation? CytD- and Blebbistatin-treated embryos
exhibit ‘floppy’ neural folds (Ybot-Gonzalez and Copp, 1999)
(supplementary material Table S2), and yet still progress in spinal
neurulation. This suggests that diminished neuroepithelial tension is
compatible with closure, provided theMHP and DLHPs are formed.
Interestingly, embryos exposed to ML-7 did not exhibit floppy
neural folds (supplementary material Table S2), suggesting that
ATPase-dependent myosin II contractility is unlikely to be limiting
for generation of neuroepithelial tension. Alternatively, ATPase-
independent myosin contraction could play a role. In other systems,
actomyosin ring contraction can result from dynamic de- and
re-polymerization of actin filaments, independently of ATPase
activity (Henson et al., 2002; Pelham and Chang, 2002; Sun et al.,
2010). Hence, regulated assembly and disassembly of apical
F-actin, mediated by ROCK and cofilin signalling, could be an
important mechanism for generating neuroepithelial tension during
spinal neurulation. We propose, therefore, that accumulation of
actomyosin might generate excessive neuroepithelial tension,
rendering the neural plate stiff and resistant to morphogenesis,
despite the presence of MHP and DLHPs.
Adherens junctions and spinal neurulation
A further aspect of neuroepithelial tension maintenance likely
involves adherens junctions, which were consistently disturbed in
neuroepithelia with actomyosin accumulation. Apical junctional
complexes regulate epithelial integrity, polarity and dynamic
intercellular movements during morphogenesis (Nishimura and
Takeichi, 2009). In chick neurulation, PCP- and ROCK-mediated
neuroepithelial cellular rearrangement depends onmyosin cables that
connect junctional complexes of adjacent cells (Nishimura et al.,
2012), whereas adherens junctions remodelling is also strongly
dependent on RhoA and ROCK activity in other systems (Fang et al.,
2008; Sahai and Marshall, 2002). In Drosophila amnioserosa cells,
actin stabilization with Jasp inhibited the redistribution of adherens
junctions and increased the number of adherens junctions
(Goldenberg and Harris, 2013). It seems likely, therefore, that the
abnormal adherens junctions we observed in embryos with defective
spinal neurulation resulted from disruption of the dynamic
actomyosin assembly–disassembly cycle, and contributed to faulty
neuroepithelial tension in embryos with faulty PNP closure.
Myosin dynamics and neural tube closure
Blebbistatin blocks myosin II in an actin-detached state (Kovacs
et al., 2004), thereby inhibiting two of its key functions, ATP-
binding required for motor activity and actin cross-linking
required for development of tension, independently of MLC
phosphorylation (Bresnick, 1999; Wang et al., 2011). Given that
spinal neurulation continued in the presence of Blebbistatin, we
conclude that neither of these functions is limiting for closure. In
fact, enhanced actin crosslinking by myosin II could also
contribute to the postulated increase in neuroepithelial tension in
embryos that fail in spinal closure. Of the three myosin II heavy
chains, MHCB is the predominant isoform expressed in
neuroepithelial cells (Wang et al., 2011) and fetal brain (Golomb
et al., 2004), whereas MHCA and MHCC (also known as MYH9
and MYH14, respectively) are present at only low levels. MHCB is
characterized by a high ‘duty ratio’, with strong ADP-binding and
propensity to exist in a rigor state, tightly bound to actin (Rosenfeld
et al., 2003; Wang et al., 2003). The striking translocation of
MHCB to the apical neuroepithelial surface in embryos with
ROCK inhibition (and hence increased cofilin activity) suggests
that apical actin may be stabilized by MHCB, further diminishing
actomyosin disassembly. Interestingly, the opposite effect, in
which myosin and F-actin were found to accumulate basally in the
neuroepithelium, was recently described in the cranial region of
Cfl1 mutants (Grego-Bessa et al., 2015).
Fig. 7. Contribution of adherens junction disruption and summary of
cytoskeletal signalling requirements for spinal neural tube closure.
(A) Immunohistochemistry (phalloidin, red; anti-β-catenin, green) reveals
precise colocalization of β-catenin and phalloidin at neuroepithelial adherens
junctions of E9.5 WT embryos, which is severely disrupted in Cfl1−/−
littermates. Culture in Y27632 or Jasp disrupts colocalization of β-catenin and
phalloidin at adherens junctions of the 15–19 somite embryos compared with
DMSO controls, whereasML-7 or Blebbistatin have no adverse effects. Culture
in Y27632+Blebbistatin restores a normal staining pattern. Arrowheads,
normal staining; asterisks, disrupted staining pattern. Enlargements of the
boxed regions are shown for β-catenin alone and the β-catenin and phalloidin
merged views. Embryos have 18–21 somites. Scale bars: 30 µm.
(B) Summary of cytoskeletal signalling requirements for spinal neural tube
closure, based on findings in the study. Normal closure (B1) requires signalling
through RhoA, ROCK, LIMK and cofilin to regulate actin turnover and
actomyosin disassembly. We suggest this is a prerequisite for both
actomyosin-based neuroepithelial tension and ATPase-independent myosin
contraction, the latter regulating remodelling of adherens junctions (AJs)
without affecting tight junctions (TJs). Myosin ATPase-dependent contractile
activity regulated by MLC phosphorylation is not limiting for spinal NT closure,
as closure is not inhibited by ML-7. Failure of closure (B2) results when RhoA
and ROCK signalling is inhibited by Y27632 (left arrows in B2), with apical
actomyosin accumulation, probably because of enhanced cofilin activity,
leading to F-actin-assembly through increased actin nucleation. Closure also
fails when F-actin is stabilized (right arrows in B2), in Jasp-treated embryos or
following the decrease of actin-severing activity in Cfl1 mutants, similarly
leading to actomyosin accumulation. Abnormal adherens junctions and
disruption of neuroepithelial tension are suggested to result from actomyosin
accumulation, and prevent spinal closure.
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How Blebbistatin acts to diminish actomyosin accumulation in
the apical neuroepithelium, and rescue spinal neural tube closure, is
unclear. As noted above, Blebbistatin inhibits actin cross-linking
and this might help prevent actomyosin from accumulating.
However, we also observed rescue when Blebbistatin was added
to embryos that had been cultured for extended periods in ROCK
inhibitor. This might suggest that Blebbistatin can enhance the
disassembly of actomyosin, although the mechanism of this putative
action is unknown.
Stage and species variations in cytoskeletal requirement for
neurulation
The onset of neural tube closure is strongly dependent on the PCP
pathway in mice (Copp and Greene, 2010) and it has been shown
recently that the severe PCP closure phenotype of homozygous
loop-tail (Vangl2Lp) embryos is further exacerbated by co-
inactivation of Cfl1 or by Jasp treatment. This confirmed a role
for F-actin turnover in PCP initiation at the onset of closure
(Mahaffey et al., 2013). Once closure has been initiated, at the
brain–spine boundary, the cranial neural plate undergoes major
morphogenetic changes, starting with expansion of bi-convex
neural folds, followed by dorsolateral bending, which brings the
neural fold tips together in the dorsal midline (Morriss-Kay, 1981).
This latter event has been found to be exquisitely sensitive to
disruption of apical actin microfilaments, with cytochalasins
causing exencephaly both in vivo and in vitro (Austin et al., 1982;
Morriss-Kay and Tuckett, 1985; Wiley, 1980). We observed cranial
neural tube defects in embryos cultured in Blebbistatin and LatB
(data not shown), suggesting a general requirement for contractile
actomyosin in cranial neural folding. Following completion of
cranial neurulation, the spinal neural tube ‘zips up’ along the body
axis to complete closure of the primary neural tube, and this process
has strikingly different cytoskeletal requirements from cranial
closure where regulation of neuroepithelial tension is required with
a key role for ATPase-independent actomyosin dynamics.
In contrast to mammals, lower vertebrates appear to be more
completely reliant on ATPase-dependent actomyosin contraction for
neural tube closure. Chick embryos exposed to Blebbistatin exhibit
severe neural tube defects due to defective apical constriction
(Kinoshita et al., 2008) whereas myosin II knockdown in Xenopus
laevis impairs neural plate bending (Rolo et al., 2009). These
differences between animal groups might reflect the somewhat
‘simpler’ pattern of neurulation events in birds and amphibians
where closure of brain and spine are relatively homogeneous in
timing and morphology compared with mammals, where the events
along the body axis cover a long developmental period and are
morphologically extremely diverse (Morriss-Kay, 1981).
MATERIALS AND METHODS
Breeding and genotyping of mouse strains
Mouse procedures were performed under the UK Animals (Scientific
Procedures) Act 1986 and ‘Responsibility in the Use of Animals forMedical
Research’ (Medical Research Council, 1993). Cfl1-knockout mice were
bred and genotyped as described previously (Gurniak et al., 2005).
Non-mutant embryos were from random-bred CD1 mice.
Embryo collection and culture
After overnight mating, pregnant females were killed at E8.5–E9.5 days of
gestation (E0.5 is noon on the day of the copulation plug). Embryos were
dissected in Dulbecco’s modified Eagle’s medium (Invitrogen) containing
10% fetal bovine serum (Sigma). Following whole embryo culture (Copp
et al., 2000), or immediately after dissection of non-cultured embryos,
somites were counted and PNP length was measured using an eyepiece
graticule on a Zeiss SV11 stereomicroscope. Embryos for immunostaining
were fixed for 1 h in 4% paraformaldehyde (PFA) in phosphate-buffered
saline (PBS), embedded in 7.5% gelatin in 15% sucrose in PBS and
cryosectioned. Embryos for protein extraction were rinsed twice in ice-cold
PBS, snap frozen on liquid N2 and stored at −80°C. For western blotting,
F-actin and G-actin ratio and Rho activation assays, PNP and ‘body’
fragments were generated by cutting at the rostral border of the most recently
formed somite pair. Both fragment types were assayed separately.
Chemical inhibitors
Inhibitors were prepared as stock solutions in DMSO and stored frozen as
follows: Cytochalasin D (C8273, Sigma, 100 mg/ml), Latrunculin B
(catalogue no. 428020, Calbiochem, 25 mg/ml), Blebbistatin (catalogue
no. 203390, Calbiochem, 75 mg/ml), ML-7 (catalogue no. 12764, Sigma,
10 mM), Y27632 (catalogue no. 688000, Calbiochem, 5 mM), HA-1100
(catalogue no. 390602, Calbiochem, 10 mM), Jasplakinolide (catalogue no.
420107, Calbiochem, 1 mM). Immediately prior to use, stocks were diluted
with DMSO and added to embryo culture serum to a maximum of 0.1%
(v/v). Culturing was performed in the dark to avoid photo-inactivation.
Protein extraction and western blotting
Proteins were extracted from frozen unfixed tissue by sonication in RIPA
buffer (1%Nonidet P-40,150 µMNaCl, 10 µM Tris-HCl pH 8, 1× complete
protease inhibitor cocktail, in PBS). Tissue lysates were cleared of
unbroken cells by centrifugation (2000 g), electrophoresed on 10% or
4–12% Bis-Tris gels (NuPage, Invitrogen) and transferred onto PVDF
membrane (XCell II Blot Module, Invitrogen). Primary antibodies for
immunodetection are described in supplementary material Table S4.
Detection was by horseradish-peroxidase-conjugated secondary antibodies
(DAKO), followed by development with the ECL prime western blotting
detection system (GE Healthcare). Autoradiographs were scanned using a
GS-800 Imaging Densitometer (Bio-Rad) and analysed with Quantity One
software (Bio-Rad).
F-actin and G-actin ratio and Rho activation assays
The ratio of free monomeric actin (G-actin) to ﬁlamentous actin (F-actin)
was determined by fractionation. Cells were lysed in ice-cold PHEM buffer
(60 mM Pipes, 20 mM HEPES, 10 mM EGTA, 2 mM MgCl2, pH 7.0, 1%
Triton X-100). Cleared lysates (2000 g) were centrifuged at 10,000 g to
separate Triton-X-100-soluble G-actin from Triton-X-100-insoluble
F-actin. Supernatant containing G-actin was collected, and the F-actin
pellet was washed twice in cold PHEM buffer and suspended in SDS buffer.
Fractions were proportionally loaded onto SDS-polyacrylamide gels,
electrophoresed and transferred onto PVDF membrane for probing with
an anti-actin antibody (A5316, Sigma). Densitometric quantification of the
western blot was used to determine the G-actin versus F-actin content.
Activated RhoA was determined by using the RhoA G-LISA Activation
Assay kit (catalogue no. BK124, Cytoskeleton Inc.) according to the
manufacturer’s instructions. Active GTP-bound RhoA in protein lysates was
bound to RhoA-GTP-binding proteins linked to the wells of a 96-well plate,
whereas inactive GDP-bound forms were removed during wash steps. GTP-
bound Rho was detected by indirect immunofluorescence using anti-RhoA
antibody. Absorbance was measured at 490 nm using a microplate
spectrophotometer reader (BioTek synergy HT). Total RhoA was
determined by an ELISA assay (catalogue no. BK150, Cytoskeleton Inc.).
Assays were performed with duplicate measures.
Immunohistochemistry
Gelatin was removed from cryosections by incubation in PBS for 30 min at
37°C. Samples were blocked and permeabilized in 10% sheep serum and
0.1% Tween-20 in PBS, incubated with primary antibody overnight at 4°C,
rinsed in PBS, and incubated with secondary antibody for 1 h at room
temperature. For F-actin, sections were incubated in phalloidin (Alexa-
Fluor-568–phalloidin, A12380, Life Technologies) for 1 h at room
temperature. Samples were washed with 4′,6-diamidino-2-phenylindole
(DAPI) and mounted in Mowiol 4-88 mounting medium (Sigma-Aldrich,
MO; prepared with glycerol and 0.2 M Tris-HCl pH 6.8). Primary
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antibodies are described in supplementary material Table S4. The secondary
antibody was Alexa-Fluor-488-conjugated goat anti-rabbit-IgG (A11070,
Life Technologies).
Cell proliferation and cell death analysis
Immunostaining was performed for phosphorylated histone H3 (Millipore)
and cleaved caspase 3 (Cell Signaling) on 12-μm transverse crysections at
the axial level of the closing spinal neural tube (17–19 somites).
Fluorescence images were collected using a Zeiss Axiophot microscope
with Leica DC500 camera and FireCam software. Images were analysed
using the Cell Counter plugin of the ImageJ software. Phosphorylated-
histone-H3- or caspase-3-positive cells were counted and expressed as a
percentage of the total cell number visualized by DAPI staining. Three
embryos per treatment were analysed and, for each embryo, cells from at
least three sections were counted.
MHP and DLHP scoring
During spinal neural plate bending, the MHP is defined as an acute (focal)
midline bend in the neural plate, present during the early stages (Modes 1
and 2) of mouse spinal neurulation. At the latest stage (Mode 3), an MHP is
absent: the midline neural plate is not focally bent, but gradually or
uniformly curved, or even flat (Shum and Copp, 1996). These criteria were
used to score the MHP as either present or absent, after inspection of serial
sections throughout the PNP. For examples of MHP-positive neural plates,
see Fig. 2A (DMSO) and Fig. 3C (DMSO), whereas MHP-negative neural
plates are seen in Fig. 2A (Blebb) and Fig. 3C (Jasp). DLHPs like the MHP
are characterized by an acute focal bend of the neural plate, present during
late stages of spinal neurulation (Modes 2 and 3) but not at the earliest stage
(Mode 1) (Shum and Copp, 1996). In transverse section, DLHPs are always
centred at the point where the neural plate transitions from contact with
surface ectoderm, dorsolaterally, to contact with paraxial mesoderm,
ventromedially. These criteria were used to score DLHPs as either present
or absent, after inspection of serial sections throughout the PNP. For
examples of DHLPs, see Fig. 3C, Fig. 5C and Fig. 6C.
Confocal microscopy
Labelled cells in immunohistochemistry or phalloidin-stained sections
were examined and quantified by epifluorescence on an inverted LSM710
confocal system mounted on an Axio Observer Z1 microscope (Carl Zeiss
Ltd, UK). Images were acquired at room temperature using a 63× oil
immersion objective. The thickness of optical sections was set at 0.2 to
0.9 μm. The Alexa Fluor 488 dyewas excited by a 488 nm line of an Argon
laser and Alexa Fluor 568 by a 561 nm diode laser. Z-projections of
confocal stacks were created in ImageJ. Images were further processed in
Photoshop CS3 (Adobe).
Image analysis and quantification
Between three and five adjacent immunohistochemistry or phalloidin-stained
sections were analysed per embryo. For each section and each side of the
neural plate, a region of interest (ROI) was outlined, comprising the full
thickness of the neural plate along ∼30% of the dorsoventral extent of one
hemi-plate. The fluorescence intensitywithin theROIwasmeasured using the
ImageJ function ‘Plot Profile’ integrated in custom written ImageJ macro
number 1. In this macro, ImageJ plot profile function displays a ‘column
average plot’, where the x-axis represents the basal-apical distance through the
ROI, and the y-axis represents the vertically averaged pixel intensity of the
ROI. Each curvewasnormalized to a rangeof 0–100 along the basalapical axis
(x-axis). Once normalized, the intensity values (y-axis) were interpolated
(integers between 0 and 100 for the X axis) using a custom-written Matlab
script (macro number 2) to allow statistical analysis and comparison between
samples. For some phalloidin-stained sections, the intensity values (y-axis)
were also normalized using macro number 1. Macros are available upon
request. See also supplementary material Fig. S1E.
Statistical analysis
Statistical tests were performed using SigmaStat v3.5 (Systat Software Inc).
At least three independent experiments were performed for each assay.
Acknowledgements
We thank Guillaume Charras and AnaRolo for critical reading of themanuscript, and
the Confocal Core Facility at the UCL Institute of Child Health for support.
Competing interests
The authors declare no competing or financial interests.
Author contributions
S.E. contributed to the execution, and analysis of experiments. B.V. contributed to
imaging analysis. D.S., C.B.G. andW.W. contributed tomouse genetic studies. S.E.,
N.D.E.G. and A.J.C. contributed to the concept, design and funding of experiments,
and wrote the manuscript.
Funding
This study was supported by theWellcome Trust [grant number 087525]; and the UK
Medical Research Council [grant number G0801124]. Deposited in PMC for
immediate release.
Supplementary material
Supplementary material available online at
http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.164574/-/DC1
References
Andrianantoandro, E. and Pollard, T. D. (2006). Mechanism of actin filament
turnover by severing and nucleation at different concentrations of ADF/cofilin.Mol.
Cell 24, 13-23.
Austin, W. L., Wind, M. and Brown, K. S. (1982). Differences in the toxicity and
teratogenicity of cytochalasins D and E in various mouse strains. Teratology 25,
11-18.
Bamburg, J. R. (1999). Proteins of the ADF/cofilin family: essential regulators of
actin dynamics. Annu. Rev. Cell Dev. Biol. 15, 185-230.
Bresnick, A. R. (1999). Molecular mechanisms of nonmuscle myosin-II regulation.
Curr. Opin. Cell Biol. 11, 26-33.
Chu, D., Pan, H., Wan, P., Wu, J., Luo, J., Zhu, H. and Chen, J. (2012). AIP1 acts
with cofilin to control actin dynamics during epithelial morphogenesis.
Development 139, 3561-3571.
Copp, A. J. (1985). Relationship between timing of posterior neuropore closure and
development of spinal neural tube defects in mutant (curly tail) and normal mouse
embryos in culture. J. Embryol. Exp. Morphol. 88, 39-54.
Copp, A. J. and Greene, N. D. E. (2010). Genetics and development of neural tube
defects. J. Pathol. 220, 217-230.
Copp, A., Cogram, P., Fleming, A., Gerrelli, D., Henderson, D., Hynes, A.,
Kolatsi-Joannou, M., Murdoch, J. and Ybot-Gonzalez, P. (2000). Neurulation
and neural tube closure defects. Methods Mol. Biol. 136, 135-160.
Cramer, L. P. (1999). Role of actin-filament disassembly in lamellipodium
protrusion in motile cells revealed using the drug jasplakinolide. Curr. Biol. 9,
1095-1105.
Fang, W. B., Ireton, R. C., Zhuang, G., Takahashi, T., Reynolds, A. and Chen, J.
(2008). Overexpression of EPHA2 receptor destabilizes adherens junctions via a
RhoA-dependent mechanism. J. Cell Sci. 121, 358-368.
Flanagan, M. D. and Lin, S. (1980). Cytochalasins block actin filament elongation
by binding to high affinity sites associated with F-actin. J. Biol. Chem. 255,
835-838.
Ghosh, M., Song, X., Mouneimne, G., Sidani, M., Lawrence, D. S. and
Condeelis, J. S. (2004). Cofilin promotes actin polymerization and defines the
direction of cell motility. Science 304, 743-746.
Goldenberg, G. and Harris, T. J. C. (2013). Adherens junction distribution
mechanisms during cell-cell contact elongation in Drosophila. PLoS. ONE 8,
e79613.
Golomb, E., Ma, X., Jana, S. S., Preston, Y. A., Kawamoto, S., Shoham, N. G.,
Goldin, E., Conti, M. A., Sellers, J. R. and Adelstein, R. S. (2004). Identification
and characterization of nonmuscle myosin II-C, a new member of the myosin II
family. J. Biol. Chem. 279, 2800-2808.
Greene, N. D. E., Gerrelli, D., Van Straaten, H. W. M. and Copp, A. J. (1998).
Abnormalities of floor plate, notochord and somite differentiation in the loop-tail
(Lp) mouse: a model of severe neural tube defects. Mech. Dev. 73, 59-72.
Grego-Bessa, J., Hildebrand, J. and Anderson, K. V. (2015). Morphogenesis of
the mouse neural plate depends on distinct roles of cofilin 1 in apical and basal
epithelial domains. Development 142, 1305-1314.
Gurniak, C. B., Perlas, E. andWitke, W. (2005). The actin depolymerizing factor n-
cofilin is essential for neural tube morphogenesis and neural crest cell migration.
Dev. Biol. 278, 231-241.
Haigo, S. L., Hildebrand, J. D., Harland, R. M. and Wallingford, J. B. (2003).
Shroom induces apical constriction and is required for hingepoint formation during
neural tube closure. Curr. Biol 13, 2125-2137.
Henson, J. H., Nazarian, R., Schulberg, K. L., Trabosh, V. A., Kolnik, S. E.,
Burns, A. R. and McPartland, K. J. (2002). Wound closure in the lamellipodia of
2480
RESEARCH ARTICLE Journal of Cell Science (2015) 128, 2468-2481 doi:10.1242/jcs.164574
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
single cells: mediation by actin polymerization in the absence of an actomyosin
purse string. Mol. Biol. Cell 13, 1001-1014.
Hildebrand, J. D. (2005). Shroom regulates epithelial cell shape via the apical
positioning of an actomyosin network. J. Cell Sci. 118, 5191-5203.
Hildebrand, J. D. and Soriano, P. (1999). Shroom, a PDZ domain–containing actin-
binding protein, is required for neural tube morphogenesis in mice. Cell 99,
485-497.
Kinoshita, N., Sasai, N., Misaki, K. and Yonemura, S. (2008). Apical accumulation
of Rho in the neural plate is important for neural plate cell shape change and
neural tube formation. Mol. Biol. Cell 19, 2289-2299.
Kovacs, M., Toth, J., Hetenyi, C., Malnasi-Csizmadia, A. and Sellers, J. R.
(2004). Mechanism of blebbistatin inhibition of myosin II. J. Biol. Chem. 279,
35557-35563.
Maekawa, M., Ishizaki, T., Boku, S., Watanabe, N., Fujita, A., Iwamatsu, A.,
Obinata, T., Ohashi, K., Mizuno, K. and Narumiya, S. (1999). Signaling from
Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase.
Science 285, 895-898.
Mahaffey, J. P., Grego-Bessa, J., Liem, K. F., Jr and Anderson, K. V. (2013).
Cofilin and Vangl2 cooperate in the initiation of planar cell polarity in the mouse
embryo. Development 140, 1262-1271.
Matsumura, F. (2005). Regulation of myosin II during cytokinesis in higher
eukaryotes. Trends Cell Biol. 15, 371-377.
Morriss-Kay, G. M. (1981). Growth and development of pattern in the cranial neural
epithelium of rat embryos during neurulation. J. Embryol. Exp. Morphol. 65Suppl.,
225-241.
Morriss-Kay, G. M. and Tuckett, F. (1985). The role of microfilaments in cranial
neurulation in rat embryos: effects of short-term exposure to cytochalasin
D. J. Embryol. Exp. Morphol. 88, 333-348.
Nishimura, T. and Takeichi, M. (2008). Shroom3-mediated recruitment of Rho
kinases to the apical cell junctions regulates epithelial and neuroepithelial planar
remodeling. Development 135, 1493-1502.
Nishimura, T. and Takeichi, M. (2009). Remodeling of the adherens junctions
during morphogenesis. Curr. Top. Dev. Biol. 89, 33-54.
Nishimura, T., Honda, H. and Takeichi, M. (2012). Planar cell polarity links axes of
spatial dynamics in neural-tube closure. Cell 149, 1084-1097.
Nyholm, M. K., Abdelilah-Seyfried, S. and Grinblat, Y. (2009). A novel genetic
mechanism regulates dorsolateral hinge-point formation during zebrafish cranial
neurulation. J. Cell Sci. 122, 2137-2148.
Pelham, R. J. and Chang, F. (2002). Actin dynamics in the contractile ring during
cytokinesis in fission yeast. Nature 419, 82-86.
Rolo, A., Skoglund, P. and Keller, R. (2009). Morphogenetic movements driving
neural tube closure in Xenopus require myosin IIB. Dev. Biol. 327, 327-338.
Rosenfeld, S. S., Xing, J., Chen, L.-Q. and Sweeney, H. L. (2003). Myosin IIb is
unconventionally conventional. J. Biol. Chem. 278, 27449-27455.
Sadler, T. W., Greenberg, D., Coughlin, P. and Lessard, J. L. (1982). Actin
distribution patterns in the mouse neural tube during neurulation. Science 215,
172-174.
Sahai, E. and Marshall, C. J. (2002). ROCK and Dia have opposing effects on
adherens junctions downstream of Rho. Nat. Cell Biol. 4, 408-415.
Saitoh, M., Ishikawa, T., Matsushima, S., Naka, M. and Hidaka, H. (1987).
Selective inhibition of catalytic activity of smooth muscle myosin light chain
kinase. J. Biol. Chem. 262, 7796-7801.
Sawyer, J. M., Harrell, J. R., Shemer, G., Sullivan-Brown, J., Roh-Johnson, M.
and Goldstein, B. (2010). Apical constriction: a cell shape change that can drive
morphogenesis. Dev. Biol. 341, 5-19.
Schoenwolf, G. C. and Franks, M. V. (1984). Quantitative analyses of changes in
cell shapes during bending of the avian neural plate. Dev. Biol. 105, 257-272.
Schoenwolf, G. C., Folsom, D. and Moe, A. (1988). A reexamination of the role of
microfilaments in neurulation in the chick embryo. Anat. Rec. 220, 87-102.
Shimokawa, H., Seto, M., Katsumata, N., Amano, M., Kozai, T., Yamawaki, T.,
Kuwata, K., Kandabashi, T., Egashira, K., Ikegaki, I. et al. (1999). Rho-kinase-
mediated pathway induces enhanced myosin light chain phosphorylations in a
swine model of coronary artery spasm. Cardiovasc. Res. 43, 1029-1039.
Shum, A. S. W. and Copp, A. J. (1996). Regional differences in morphogenesis of
the neuroepithelium suggest multiple mechanisms of spinal neurulation in the
mouse. Anat. Embryol. 194, 65-73.
Smith, J. L. and Schoenwolf, G. C. (1988). Role of cell-cycle in regulating
neuroepithelial cell shape during bending of the chick neural plate. Cell Tissue
Res. 252, 491-500.
Smith, J. L., Schoenwolf, G. C. and Quan, J. (1994). Quantitative analyses of
neuroepithelial cell shapes during bending of the mouse neural plate. J. Comp.
Neurol. 342, 144-151.
Spector, I., Shochet, N. R., Blasberger, D. and Kashman, Y. (1989).
Latrunculins–novel marine macrolides that disrupt microfilament organization
and affect cell growth: I. Comparison with cytochalasin D. Cell Motil. Cytoskeleton
13, 127-144.
Sun, S. X., Walcott, S. and Wolgemuth, C. W. (2010). Cytoskeletal cross-linking
and bundling in motor-independent contraction. Curr. Biol. 20, R649-R654.
Tang, A. T., Campbell, W. B. and Nithipatikom, K. (2012). ROCK1 feedback
regulation of the upstream small GTPase RhoA. Cell Signal. 24, 1375-1380.
Uehata, M., Narumiya, S., Ishizaki, T., Satoh, H., Ono, T., Kawahara, T.,
Morishita, T., Tamakawa, H., Yamagami, K., Inui, J. et al. (1997). Calcium
sensitization of smooth muscle mediated by a Rho-associated protein kinase in
hypertension. Nature 389, 990-994.
Wallingford, J. B. and Harland, R. M. (2002). Neural tube closure requires
Dishevelled-dependent convergent extension of the midline. Development 129,
5815-5825.
Wang, F., Kovacs, M., Hu, A., Limouze, J., Harvey, E. V. and Sellers, J. R. (2003).
Kinetic mechanism of non-muscle myosin IIB: functional adaptations for tension
generation and maintenance. J. Biol. Chem. 278, 27439-27448.
Wang, A., Ma, X., Conti, M. A. and Adelstein, R. S. (2011). Distinct and redundant
roles of the non-musclemyosin II isoforms and functional domains.Biochem. Soc.
Trans. 39, 1131-1135.
Wei, L., Roberts, W., Wang, L., Yamada, M., Zhang, S. X., Zhao, Z. Y., Rivkees,
S. A., Schwartz, R. J. and Imanaka-Yoshida, K. (2001). Rho kinases play an
obligatory role in vertebrate embryonic organogenesis. Development 128,
2953-2962.
Wiggan, O., Shaw, A. E., DeLuca, J. G. and Bamburg, J. R. (2012). ADF/cofilin
regulates actomyosin assembly through competitive inhibition of myosin II binding
to F-actin. Dev. Cell 22, 530-543.
Wiley, M. J. (1980). The effects of cytochalasins on the ultrastructure of neurulating
hamster embryos in vivo. Teratology 22, 59-69.
Wu, M., Chen, D. F., Sasaoka, T. and Tonegawa, S. (1996). Neural tube defects
and abnormal brain development in F52-deficient mice. Proc. Natl. Acad. Sci.
USA 93, 2110-2115.
Ybot-Gonzalez, P. and Copp, A. J. (1999). Bending of the neural plate during
mouse spinal neurulation is independent of actin microfilaments. Dev. Dyn. 215,
273-283.
Ybot-Gonzalez, P., Cogram, P., Gerrelli, D. and Copp, A. J. (2002). Sonic
hedgehog and the molecular regulation of neural tube closure. Development 129,
2507-2517.
Ybot-Gonzalez, P., Gaston-Massuet, C., Girdler, G., Klingensmith, J., Arkell, R.,
Greene, N. D. E. and Copp, A. J. (2007a). Neural plate morphogenesis during
mouse neurulation is regulated by antagonism of BMP signalling. Development
134, 3203-3211.
Ybot-Gonzalez, P., Savery, D., Gerrelli, D., Signore, M., Mitchell, C. E., Faux,
C. H., Greene, N. D. E. and Copp, A. J. (2007b). Convergent extension, planar-
cell-polarity signalling and initiation of mouse neural tube closure. Development
134, 789-799.
2481
RESEARCH ARTICLE Journal of Cell Science (2015) 128, 2468-2481 doi:10.1242/jcs.164574
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
Supplementary figure legends 
Figure S1. Effect of cytoskeletal inhibitors on neural tube closure, and method of 
intensity profile analysis 
 (A-B) Mean PNP length (mm ± SEM) after treatment with different inhibitors for 5-6 h (A) 
or 18-20 h (B). P-values are from pairwise t-tests compared with DMSO controls, following 
1-way ANOVA (p < 0.05). 
(C) Embryos exposed to 12.5, 20 or 50 μM Blebbistatin for 5-6 h undergo PNP closure at the 
same rate as DMSO controls (best fit linear regression lines plotted). 
(D) Graph (top) and table (below) showing PNP length at 20-24 somites following 16-17 h 
culture is not significantly different from DMSO control after exposure to 60 μM Blebbistatin 
(a higher concentration than the 50 μM used elsewhere in the study). Similarly, a 
combination of 50 μM Blebbistatin + 0.05 μg/mL CytD, or 50 μM Blebbistatin + 50 μM ML-
7, does not yield PNP lengths significantly different from DMSO controls (P-values in table 
= 0.694 for 1-way ANOVA; p > 0.05). 
(E) Method of analysing fluorescence intensity of Phalloidin and anti-MHCB staining on 
sections through the neural plate. (E1) Fluorescence intensity was measured along the basal-
to-apical (X) axis of each region of interest. Image J function “Plot Profile” and custom 
written ImageJ macro #1 were used to provide a ‘column average profile’ for the region of 
interest. (E2) Average profile curves were normalised to a range of 0-100 along the basal-to-
apical axis. (E3) Intensity values were interpolated (integers between 0 and 100 for the X 
axis) using a custom written Matlab script (macro #2), enabling statistical analysis and 
comparison between samples. 
Figure S2. Effect of cytoskeletal inhibitors on Phalloidin intensity, F/G actin fractions 
and neural tube closure 
 (A) Intensity profile scans of Phalloidin staining along the basal-to-apical axis of the 
neuroepithelium. Basal surface = 0; apical surface = 100 (arbitrary units, a.u.). The maximum 
intensity is normalised to 100%. Note the reproducibility of the basally extended Phalloidin 
staining in individual Y27632-treated embryos compared with DMSO controls. 
(B) Biochemical fractionation shows increased F-actin and reduced G-actin in Y27632-
treated embryos, but dramatically reduced F-actin and increased G-actin in CytD-treated 
embryos (** p < 0.001 compared with DMSO control). 
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(C, D) Intensity profile scans of Phalloidin staining (C) and MHCB (D) along the basal-to-
apical axis of the neuroepithelium. Note the very low intensity of Phalloidin and MHCB in 
embryos treated with Blebbistatin + CytD or Blebbistatin + ML-7, consistent with severe 
reduction of neuroepithelial actomyosin by these inhibitors. 
(E) PNP length (mm ± SEM) is significantly increased after treatment with Jasp for 18-20 h 
to the 15-19 or 20-24 somite stage. P-values are from t-tests compared with DMSO controls. 
(F) Biochemical fractionation shows increased F-actin and reduced G-actin in Jasp-treated 
embryos compared with DMSO control embryos (** p < 0.001). 
(G) Intensity profile scans of Phalloidin staining along the basal-to-apical axis of the 
neuroepithelium in embryos treated with Jasp or DMSO. The maximum intensity is 
normalised to 100%. Note the reproducibility of the basally extended Phalloidin staining in 
individual Jasp-treated embryos, compared with DMSO controls. 
(H, I) Quantitation of cell proliferation by % phospho-histone H3 positive nuclei (H) and 
programmed cell death by % cleaved caspase 3 positive cells (I) in embryos cultured in 
Y27632 or Jasp for 18-20 h. There is no statistical difference between either treatment group 
and DMSO control embryos. 
Figure S3. Effects of cytoskeletal inhibitors on neural tube closure and F/G actin 
fractions, and rescue of Y27632-induced and Jasp-induced defects by Blebbistatin 
(A) Mean PNP length (mm ± SEM) after treatment with 50 μM ML-7 or DMSO for 5-6 h. 
There is no significant difference between ML-7 and DMSO-treated embryos at either 15-19 
or 20-24 somites.  P-values are from t-tests compared with DMSO controls.  
(B) Embryos exposed to varying concentrations of ML-7 for 5-6 h undergo PNP closure at a 
similar rate as DMSO-treated controls (best fit linear regression lines plotted). 
(C) Mean PNP length (mm ± SEM) after treatment with DMSO, Y27632, Y27632 + 
Blebbistatin, Y27632 + ML-7 for 15-18h. Note the rescue of PNP closure delay in Y27632- 
treated embryos by Blebbistatin, but not by ML-7. P-values are from pairwise t-tests 
compared with DMSO controls, following 1-way ANOVA (p < 0.05) 
(D, E) Mean PNP length (mm ± SEM) after Y27632 treatment for 5-6 h followed by 
Blebbistatin for 13-15 h (D) or treatment with Y27632 + Blebbistatin for 5-6 h to the 15-19 
or 20-24 somite stage (E). In both cases, PNP length does not differ from DMSO controls. P-
values are from t-tests compared with DMSO controls. 
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(F, H) Mean PNP length (mm ± SEM) after culture for 5-6 h (Short Term Culture, STC) or 
15-18 h (Long Term Culture, LTC), shown graphically (F) and in table form (H, lower). 
Y27632 produces enlarged PNPs (pink symbols) but this effect is reversed if embryos are 
cultured in rat serum alone after removal (‘washout’) of Y27632 (STC Y27632 then RS). 
However washout with rat serum after longer exposure to Y27632 does not restore PNP 
length (LTC Y27632 then RS) whereas subsequent culture in Blebbistatin rescues closure 
(LTC Y27632 then Blebb). P-values are from t-tests compared with DMSO controls. 
(G, H) Mean PNP length (mm ± SEM) after culture in Y27632 followed by Blebbistatin, 
shown graphically (G) and in table form (H, upper). The effect of Y27632 in producing 
enlarged PNPs (pink symbols) is reversed when Blebbistatin is added to either short-term 
(STC Y27632 then Blebb) or long-term cultures (LTC Y27632 then Blebb). The same result 
is observed in embryos reaching three different somite stages.  
(I) Biochemical fractionation shows similar a F/G ratio in embryos treated with a mixture of 
Y27632 and Blebbistatin after STC or LTC in Y27632 (as in G). There are no statistical 
differences in F/G ratio from DMSO control embryos. 
(J, K) Exposure to a combination of 10 nM Jasplakinolide + 50 μM Blebbistatin for 15-18h 
does not significantly affect PNP closure compared with DMSO controls (p > 0.05). Compare 
with the marked PNP closure-delaying effect of Jasp alone in Fig. 3A and Fig. S2E.  
Figure S4. Actomyosin accumulation, apical junction formation, and PNP closure in 
Cofilin mutant and inhibitor-treated embryos 
(A) Mean PNP length (mm ± SEM) for wild-type (WT), Cofilin 1
+/-
 and Cofilin 1
-/-
 littermate
embryos. Note the enlarged PNPs in Cofilin 1 mutant embryos at 20-24 somites. P-values are 
from pairwise t-tests compared with WT following 1-way ANOVA (p < 0.05). 
(B) Immunohistochemistry (Phalloidin, red; anti-MHCB, green) in WT and Cofilin 1
-/-
mutants at 16 somites, preceding onset of PNP closure delay. Note apical accumulation of 
actomyosin (asterisks) in the mutant neuroepithelium. Scale bar: 30 μm in all panels 
(C, D) Apical accumulation of actomyosin and disruption of adherens junctions (Phalloidin, 
red; anti-MHCB, green in B; β-catenin, green in C) in Cofilin 1+/- embryos with a large PNP
(lower panels) compared with those with a small PNP (upper panels). The latter exhibit 
relatively normal actomyosin and β-catenin immunostaining. 
(E) Immunohistochemistry (Phalloidin: red; anti-ZO1: green) in the neuroepithelium of E9.5 
WT (upper panel) and Cofilin 1
-/-
 (lower panel) embryos. ZO1 immunostaining is disrupted in
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Cofilin 1 mutants compared with WT. Arrowheads: normal staining; asterisks: disrupted 
staining pattern. Right panels show enlargements of boxed regions. Scale bar: 30 μm in all 
panels. 
(F) Immunohistochemistry (anti-ZO1: green) in the neuroepithelium of E9.5 embryos 
following culture with inhibitors for 6 or 18 h. ZO1 immunostaining is unaffected in 
inhibitor-treated embryos compared with DMSO controls. Embryos have 18-21 somites. 
Arrowheads: normal staining. Scale bar: 30 μm in all panels. 
(G) Immunohistochemistry (Phalloidin, red; anti-MHCB, green, middle; anti-β-catenin, 
green, right) reveals a less severely disrupted actomyosin distribution in Cofilin 1 mutant 
embryos exposed to Blebbistatin (G) compared with untreated Cofilin 1 mutants (compare 
with Figs 6C, S4B). Blebbistatin treatment is also able to restore normal β-catenin staining 
(compare with Fig. 7A). 
(H) In contrast, Cofilin 1 embryos exposed to Blebbistatin show abnormal ZO1 staining, 
indicating that TJ structure is not rescued (compare with Fig. S4E). Asterisks: abnormal 
immunostaining. 
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Table S1. 
Dose-response experiments used to select inhibitor concentrations for embryo culture a Table S1 - Dose-response experiments used to select inhibitor concentrations for embryo culture a
Inhibitor Action Concentration
 b 
Yolk sac circulation Heart beat Normal overall morphology 
c
CytD Blocks actin polymerisation 0.05 µg/mL 22/23  23/23  23/23
0.1 µg/mL  1/6  3/6 1/6
LatB Blocks actin polymerisation 500 nM  3/3  3/3 3/3
1 µM  4/4  4/4 4/4
2.5 µM  3/3  3/3 3/3
5 µM  3/3  3/3 3/3
10 µM  11/13  11/13 11/13
20 µM  1/4  2/4 2/4
Blebbistatin Inhibits myosin ATPase activity 12.5  µM 
d
 8/9  9/9 9/9
20  µM 
d
24/26  26/26 24/6
50  µM 
d
 28/32  32/32 29/32
75 µM 
d
 1/3  2/3 1/3
100  µM 
d
 0/4  0/4 0/4
Y27632 Inhibits Rho kinase ROCK 5 µM 
e
 42/43  43/43 43/43
10 µM 
e
 2/6  4/6   2/6
HA-1100 Inhibits Rho kinase ROCK 10 µM  4/4  4/4 4/4
20 µM  9/9  9/9 9/9
30 µM  0/3  0/3 0/3
50 µM  0/3  0/3 0/3
ML-7 Inhibits myosin light chain kinase MLCK 5 µM  3/3  3/3 3/3
10 µM  3/3  3/3 3/3
20 µM  5/6  6/6 6/6
30 µM  10/10  10/10 10/10
50 µM  17/18  18/18 18/18
75 µM  7/7  7/7 7/7
100 µM  8/9  9/9 8/9
125 µM  1/5  2/5 1/5
Jasplakinolide Blocks F-actin depolymerisation 10 nM 
e
 31/32  32/32 32/32
50 nM 
e
 0/2  1/2 0/2
100 nM 
e
 0/3  0/3 0/3
a
 Embryos were cultured for 18-20h to the 15-24 somite stage, after which presence of yolk sac circulation and heart beat were evaluated as measures of viability.
b
 Concentrations in red are those used in the experimental studies.
c
 Overall morphology was scored with the following defects considered 'abnormal': non-smooth and round yolk sac, non-well formed branchial arches and maxillary, 
abnormal shaped somites.
d
 The heart was bigger and the beating slower in Blebbistatin-treated embryos at all concentrations tested
e
 Ssome embryos treated with Y27632 or jasplakinolide did not complete axial rotation
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Table S2. 
Number of embryos that exhibited MHP and DLHP bending in the PNP following 
culture in inhibitors Table S2.  Number of embryos that exhibited MHP and DLHP bending in the PNP following culture in inhibitors
Bending regions Non-bending regions
MHP 
a
DLHP 
a
Rigidity 
b
Short cultures (5-6 h)
15-19 somites
DMSO 20/20 20/20 normal, straight
CytD 6/6 6/6 loss of rigidity/buckle 
Blebbistatin 13/13 13/13 loss of rigidity/buckle 
Y27632 14/14 14/14 normal, straight
Y27632 + Blebbistatin 7/7 7/7 normal, straight
ML-7 6/6 6/6 normal, straight
20-24 somites
DMSO 21/26 26/26 normal, straight
CytD 10/10 10/10 loss of rigidity/buckle
Blebbistatin 8/9 9/9 loss of rigidity/buckle
Y27632 3/9 9/9 normal, straight
Y27632 + Blebbistatin 8/9 9/9 normal, straight
ML-7 11/12 12/12 normal, straight
Long cultures (18-20 h)
15-19 somites
DMSO 17/19 19/19 normal, straight
CytD 4/4 4/4 loss of rigidity/buckle 
Blebbistatin 3/3 3/3 loss of rigidity/buckle 
Y27632 20/21 21/21 normal, straight
Jasplakinolide 16/16 16/16 normal, straight
20-24 somites
DMSO 39/45 45/45 normal, straight
CytD 3/3 3/3 loss of rigidity/buckle
Blebbistatin 6/7 7/7 loss of rigidity/buckle
Y27632 3/22 22/22 normal, straight
Jasplakinolide 2/16 16/16 normal, straight
Y27632 + Blebbistatin 9/10 10/10 normal, straight
Y27632 + ML-7 4/14 14/14 normal, straight
a
Values are number with MHP or DLHP/total number of embryos analysed.
b
Morphological assessment of non-bending regions of neural plate which are normally straight.
c 
Note that MHP bending was absent from the majority of Y327632- and Jasp-treated embryos at 20-24 somites, but not at 15-19 somites.
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Table S3. 
Number of Cofilin 1 mutant embryos that exhibited MHP and DLHP bending in the 
PNP 
Table S3.  Number of Cofilin 1 mutant embryos that exhibited MHP and DLHP bending in the PNP
Bending regions Non-bending regions
MHP 
a
DLHP 
a
Rigidity 
b
15-19 somites
WT 9/9 9/9 normal, straight
Cofilin 1 
+/-
3/3 3/3 normal, straight
Cofilin 1 
-/- 
6/6 6/6 normal, straight
20-24 somites
WT 13/14 14/14 normal, straight
Cofilin 1 
+/-
9/10 10/10 normal, straight
Cofilin 1 
-/- 
2/5
 c
5/5 normal, straight
a
Values are number with MHP or DLHP/total number of embryos analysed.
b
Morphological assessment of non-bending regions of neural plate which are normally straight.
c 
Note that MHP bending was absent from the majority of cofilin 1 homozygotes at 20-24 somites.
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Table S4. 
Primary antibodies 
Protein specificity Supplier Usage * 
Cofilin sc-8441, Santa Cruz WB 
pCofilin #3313, Cell Signaling WB 
LIMK sc-8389, Santa Cruz WB 
pLIMK #3841, Cell Signaling WB 
MLC #3672, Cell Signaling WB 
pMLC #3671, Cell Signaling WB 
GAPDH MAB374, Millipore WB, IHC 
β-catenin ab16051, abcam IHC 
MHCIIB PRB-445P, Covance IHC 
ZO1 #40-2200, Life technologies IHC 
PHH3 06-570, Millipore IHC 
Cleaved-Caspase 3 #9661, Cell signaling IHC 
* WB, Western blot; IHC, immunohistochemistry
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